Immunosurveillance shapes the emergence of neo-epitope landscapes of sarcomas, revealing prime targets for immunotherapy
Matched blood and tumor tissue for patients in the MOTOR study was used to identify potential tumor antigens and MHC haplotype to assess tumor immune surveillance.